Almac Group Launches US Serialisation Solution
News May 12, 2016
Almac Group has announced an expansion to its serialisation capabilities to include its US commercial packaging facility in Audubon, PA. Building upon Almac’s in-house expertise and proprietary serialisation / track and trace solution developed at its UK headquarters, this technology expansion will address FDA regulations meeting the requirements outlined in the Drug Quality and Security Act together with meeting client demand for a local US, flexible, contract packaging serialisation provider.
Having assessed multiple vendors, Almac partnered with Optel Vision to provide a versatile line level solution (hardware and software) that integrated with Almac’s in-house proprietary level 3, site level software. This new serialisation solution is a high-spec standalone line that prints, verifies and aggregates saleable packs through to the pallet with reporting functionality to ensure the client can meet the traceability requirements of the various markets.
Grainne Hughes, Operations Manager at Almac explains “Having built our own serialisation line for the UK operations some years ago we developed a strong knowledge base. To expand the solution into our US operations we decided that we needed an experienced partner that could integrate with our innovative product serialisation site level software. The partnership with Optel Vision has provided our US commercial packaging facility with a truly flexible and adaptable solution to readily meet specific country, market and client requirements whilst ensuring serialisation to GS1 Standards.”
“We knew Almac had its own in-house solution for the UK and for the first Almac serialisation project in the US, we combined the knowledge of both companies to design a solution that meets Almac quality standards as well as the demand from global markets using the Optel Vision hardware and software solutions. The system is now operational and can be easily scalable for future needs.” says Yvon Lemay, Optel Vision Project Manager.
Almac US can now offer the flexibility to our Clients to serialise as part of the pack process, as part of a repackaging exercise, or as a stand-alone serialisation application to already packed product.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018